BIOGEN INC. Quarterly Depreciation in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Biogen Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q3 2024.
  • Biogen Inc. Depreciation for the quarter ending September 30, 2024 was $72.7M, a 13.4% increase year-over-year.
  • Biogen Inc. Depreciation for the twelve months ending September 30, 2024 was $277M, a 8.61% increase year-over-year.
  • Biogen Inc. annual Depreciation for 2023 was $254M, a 6.68% decline from 2022.
  • Biogen Inc. annual Depreciation for 2022 was $272M, a 15.8% increase from 2021.
  • Biogen Inc. annual Depreciation for 2021 was $235M, a 16.5% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $277M $72.7M +$8.6M +13.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $269M $71.9M +$7.4M +11.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $261M $69.3M +$7.2M +11.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $254M $63.5M -$1.2M -1.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $255M $64.1M -$100K -0.16% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $256M $64.5M -$2.7M -4.02% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $258M $62.1M -$14.2M -18.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-24
Q4 2022 $272M $64.7M -$2M -3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $274M $64.2M -$900K -1.38% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $275M $67.2M +$12.5M +22.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-25
Q1 2022 $263M $76.3M +$27.5M +56.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-25
Q4 2021 $235M $66.7M +$16M +31.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $219M $65.1M +$13.6M +26.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 $206M $54.7M +$3.4M +6.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-20
Q1 2021 $202M $48.8M +$400K +0.83% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $202M $50.7M +$5.5M +12.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 $196M $51.5M +$6M +13.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 $190M $51.3M +$4.3M +9.15% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 $186M $48.4M -$4.5M -8.51% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $191M $45.2M -$30.2M -40.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 $221M $45.5M -$19.3M -29.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 $240M $47M -$17.2M -26.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 $257M $52.9M -$12.1M -18.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $269M $75.4M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 $64.8M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $64.2M Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $65M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.